USANA Health Sciences Provides FY 2026 Earnings Guidance

The company expects earnings per share between $1.95 and $2.29 on revenue of $925 million to $1 billion.

Mar. 3, 2026 at 6:31am

Got story updates? Submit your updates here. ›

USANA Health Sciences (NYSE:USNA), a Utah-based nutritional supplements and personal care products company, has released its fiscal year 2026 earnings guidance. The company expects earnings per share in the range of $1.95 to $2.29, compared to the consensus estimate of $1.80. USANA also provided revenue guidance of $925 million to $1 billion, versus the consensus estimate of $943.7 million.

Why it matters

USANA's updated guidance provides investors with insight into the company's expected financial performance for the upcoming fiscal year. As a publicly traded company, USANA's earnings and revenue projections are closely watched by analysts and investors to gauge the overall health and growth potential of the business.

The details

USANA Health Sciences, which operates primarily through a direct selling model, serves markets in North America, Asia Pacific, Europe, and Latin America. The company has invested heavily in research and development and quality control to support its portfolio of vitamins, minerals, dietary supplements, weight-management products, and skin-care formulations.

  • USANA Health Sciences provided the FY 2026 earnings guidance on March 3, 2026.

The players

USANA Health Sciences

A Utah-based company that develops, manufactures, and distributes nutritional supplements and personal care products through a network of independent distributors.

Got photos? Submit your photos here. ›

The takeaway

USANA's updated earnings and revenue guidance for fiscal year 2026 suggests the company is positioning itself for continued growth and profitability, despite potential headwinds in the broader nutritional supplements and personal care products industry.